Volume 45, Issue 35, 14 September 2024

Issue @ A Glance

The fascinating story of lipid-lowering drugs, sodium-glucose co-transporter 2 inhibitors and GLP1-R agonists: new light shed on their beneficial effects

Filippo Crea

European Heart Journal, Volume 45, Issue 35, 14 September 2024, Pages 3187–3191, https://doi.org/10.1093/eurheartj/ehae586

• Extract
• View article

CardioPulse

Multi-stakeholder workshop on reducing population-wide dietary sodium intake in Nigeria

Chisom Obiezu-Umeh and others

European Heart Journal, Volume 45, Issue 35, 14 September 2024, Pages 3192–3194, https://doi.org/10.1093/eurheartj/ehae461

• Extract
• View article

The ESC Working Group on Cellular Biology of the Heart

Cinzia Perrino and others

European Heart Journal, Volume 45, Issue 35, 14 September 2024, Pages 3195–3198, https://doi.org/10.1093/eurheartj/ehae017

• Extract
• View article

In memoriam: Akira Endo

Alberico L Catapano and others

European Heart Journal, Volume 45, Issue 35, 14 September 2024, Pages 3199–3200, https://doi.org/10.1093/eurheartj/ehae470

• Extract
• View article

Weekly Journal Scan

Weekly Journal Scan: an ounce of PREVENTion is worth more than a pound of stents

Rocco Vergallo and Leonarda Galiuto

European Heart Journal, Volume 45, Issue 35, 14 September 2024, Pages 3201–3203, https://doi.org/10.1093/eurheartj/ehae385

• Extract
• View article

State of the Art Review

Editor's Choice

Artificial intelligence-enhanced patient evaluation: bridging art and science

Evangelos K Oikonomou and Rohan Khera

European Heart Journal, Volume 45, Issue 35, 14 September 2024, Pages 3204–3218, https://doi.org/10.1093/eurheartj/ehae415

• Abstracts
• View article

Meta-analysis

Lipid lowering for prevention of venous thromboembolism: a network meta-analysis

Ioannis T Farmakis and others

European Heart Journal, Volume 45, Issue 35, 14 September 2024, Pages 3219–3227, https://doi.org/10.1093/eurheartj/ehae361

• Abstracts
• View article
• Supplementary data

Editorial

From arteries to veins: the expanding role of lipid-lowering drugs in preventing thrombosis

Stephan Nopp and others

European Heart Journal, Volume 45, Issue 35, 14 September 2024, Pages 3228–3230, https://doi.org/10.1093/eurheartj/ehae492

• Abstract
• View article

Fast Track – Clinical Research

Sex differences in treatment of familial hypercholesterolaemia: a meta-analysis

Iulia Iatan and others

European Heart Journal, Volume 45, Issue 35, 14 September 2024, Pages 3231–3250, https://doi.org/10.1093/eurheartj/ehae417

• Abstracts
• View article
• Supplementary data

Editorial

Familial hypercholesterolaemia: need for equitable treatment in women and men

Raul D Santos

European Heart Journal, Volume 45, Issue 35, 14 September 2024, Pages 3251–3253, https://doi.org/10.1093/eurheartj/ehae464

• Abstract
• View article

Fast Track – Clinical Research

Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials

Sanjiv J Shah and others

European Heart Journal, Volume 45, Issue 35, 14 September 2024, Pages 3254–3269, https://doi.org/10.1093/eurheartj/ehae322

• Abstracts
• View article
• Supplementary data

Editorial

STEPping down diuretic therapy with semaglutide in obesity-related heart failure with preserved ejection fraction: decongestion or disease modification?

John W Ostrominski and others

European Heart Journal, Volume 45, Issue 35, 14 September 2024, Pages 3270–3273, https://doi.org/10.1093/eurheartj/ehae410

• Abstract
• View article

Clinical Research

Post-capillary pulmonary hypertension in heart failure: impact of current definition in the PH-HF multicentre study

Charles Fauvel and others

European Heart Journal, Volume 45, Issue 35, 14 September 2024, Pages 3274–3288, https://doi.org/10.1093/eurheartj/ehae467

• Abstracts
• View article
• Supplementary data

Editorial

Pulmonary hypertension in heart failure: the good, the bad, and the ugly

Stephan Rosenkranz and others

European Heart Journal, Volume 45, Issue 35, 14 September 2024, Pages 3289–3291, https://doi.org/10.1093/eurheartj/ehae518

• Abstract
• View article

Rapid Communications

Single-nucleus RNA sequencing identifies cell-type–specific effects of sodium-glucose co-transporter 2 inhibitors in human myocardial slices

Kevin Schmidt and others

European Heart Journal, Volume 45, Issue 35, 14 September 2024, Pages 3292–3295, https://doi.org/10.1093/eurheartj/ehae472

• Extract
• View article

Cardiovascular Flashlights

Pulsus alternans under left ventricular assist device in a patient with dilated cardiomyopathy and LMNA mutation

Ryohei Sakai and others

European Heart Journal, Volume 45, Issue 35, 14 September 2024, Page 3296, https://doi.org/10.1093/eurheartj/ehae485

• Extract
• View article
• Supplementary data

The role of natural compensatory mechanisms in complex congenital heart disease: haemodynamic evolution and clinical outcomes in a case of Cor triatriatum sinistrum syndrome

Guoliang Yang and others

European Heart Journal, Volume 45, Issue 35, 14 September 2024, Page 3297, https://doi.org/10.1093/eurheartj/ehae354

• Extract
• View article
• Supplementary data

Correction

Correction to: Atherosclerosis in ancient mummified humans: the global HORUS study

European Heart Journal, Volume 45, Issue 35, 14 September 2024, Page 3227, https://doi.org/10.1093/eurheartj/ehae536

• Extract
• View article